ABIONYX (EPA:ABNX) | Finanzwire

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
ABIONYX

PRESS RELEASE

published on 05/06/2025 at 21:33, 6 months 29 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Monthly statement of total voting rights and shares for ABIONYX Pharma on Euronext Paris, including total gross and net voting rights as of April 30, 2025

Euronext Paris Shares Total Voting Rights ABIONYX Pharma April 30 2025
BRIEF

published on 03/21/2025 at 07:35, 8 months 14 days ago

CIC Market Solutions recommends purchasing ABIONYX Pharma shares

Purchase Biopharma Innovative Treatments ABIONYX Pharma CIC Market Solutions
PRESS RELEASE

published on 03/21/2025 at 07:30, 8 months 14 days ago

Inside Information / Other news releases
CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions

Buy Recommendation Biopharma ABIONYX Pharma CIC Market Solutions Innovative Biomedicines
BRIEF

published on 02/28/2025 at 07:35, 9 months 4 days ago

ABIONYX strengthens its commitment against LCAT Deficiency

Rare Disease Marketing Authorization LCAT Deficiency Biomedicine Norum Disease
PRESS RELEASE

published on 02/28/2025 at 07:30, 9 months 4 days ago

Inside Information / Other news releases
ABIONYX renews commitment to treat LCAT Deficiency (Norum's disease) and provides updates on advances, including submission of Marketing Authorization Application and Orphan Disease Designation

ABIONYX LCAT Deficiency Rare Disease Day Marketing Authorization Application Orphan Disease Designation
BRIEF

published on 02/27/2025 at 19:25, 9 months 5 days ago

ABIONYX Pharma Reports Stable Revenue and Cash Position for 2024

2024 Financial Results Innovative Therapies ABIONYX Pharma Compassionate Access CRO Industry
PRESS RELEASE

published on 02/27/2025 at 19:20, 9 months 5 days ago

Inside Information / Information on annual revenues
ABIONYX Pharma reports €4.6m revenue and €3.2m cash at the end of Q4 2024. Details on business activities and financial performance included

Revenue Cash Position Financial Update Biopharma ABIONYX Pharma
BRIEF

published on 02/20/2025 at 07:35, 9 months 12 days ago

ABIONYX Pharma receives €8.7 million in support for its sepsis project

Financial Support France 2030 ABIONYX Pharma Sepsis Biomedicine
BRIEF

published on 12/11/2024 at 12:16, 11 months 24 days ago

Threshold crossing by the CDC in ABIONYX PHARMA

Voting Rights CDC Threshold Crossing ABIONYX Pharma Bpifrance Participations
BRIEF

published on 12/11/2024 at 12:13, 11 months 24 days ago

Threshold crossing by Bpifrance in ABIONYX PHARMA

Voting Rights Actions Threshold Crossing Bpifrance ABIONYX

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 41 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 46 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 16 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 11 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 16 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 16 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 46 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 25 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 51 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 1 minute ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 16 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 31 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 32 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE